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osting by EAbstract The present study is to investigate the antioxidant activity in alloxan induced diabetic
rats. The experimental rats were randomly divided into three groups: Group I: control; Group
II: alloxan induced diabetic rats and Group III: alloxan induced diabetic rats were treated with eth-
anolic extract ofCrinum asiaticum leaves (200 mg/kg/bw). Diabetes mellitus was induced by alloxan
in a single dose of 200 mg/kg/bw. A signiﬁcant decrease in blood sugar level was observed and also
an increase in high density lipoprotein (HDL) level and a decrease (P< 0.05) in cholesterol, triglyc-
eride, low density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels were observed
after 15 days of treatment with C. asiaticum extract. Besides, the activities of aspartate transaminase
(AST), alanine transaminase (ALT), alkaline phosphatase (ALP), acid phosphatase (ACP) and lac-
tate dehydrogenase (LDH) (P< 0.05) were diminished in the C. asiaticum leaves extract of the sup-
plemented group. In addition, the activity of superoxide dismutase (SOD), catalase (CAT) and
reduced glutathione (GSH) (P< 0.05) was increased by the C. asiaticum leaves extract administra-culty of Biotechnology, West
613 403, Tamil Nadu, India.
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172 S. Indradevi et al.tion and increases in lipid peroxides (LPO) in liver were found to be ameliorated after treatment.
The ﬁndings of the present investigation demonstrated the hepatocyte protective nature of C. asi-
aticum by attenuating markers of hyperglycemia-mediated oxidative stress and the antioxidant com-
petence in hepatic tissues of diabetic rats.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Diabetes mellitus is a metabolic disorder characterized by
hyperglycemia and alteration in carbohydrate, fat and protein
metabolism associated with absolute or relative deﬁciencies in
insulin secretion or insulin action (Kumar et al., 2006).
Normally blood sugar levels are tightly controlled by insu-
lin, a hormone produced by the pancreas. Insulin lowers the
blood glucose level. When the blood glucose elevates, insulin
is released from the pancreas to normalize the glucose level.
In patients with diabetes, the absence or insufﬁcient produc-
tion of insulin causes hyperglycemia. Diabetes is a chronic
medical condition, meaning that although it can be controlled,
it lasts a lifetime.
Diabetes is a common endocrine disorder affecting over 100
million people worldwide. The World Health Organization
predicts that this number may increase ﬁvefold in the near fu-
ture. In India diabetes affects 1–5% of the population. Diabe-
tes mellitus is considered as one of the ﬁve leading causes of
death in the world.
The World Health Organization (WHO) estimates that
80% of the people of developing countries rely on traditional
medicines, mostly plant-derived drugs, for their primary health
needs. Medicinal plants are commonly used in treating and
preventing speciﬁc ailments and are considered to play a signif-
icant role in health care. The use of ethanobotanicals has a
long folkloric history for the treatment of blood sugar abnor-
malities (Kiritikar and Basu, 1999).
India is well-known for its rich traditional systems of medi-
cine, i.e. Ayurvedic, Siddha,Unani andAmchi (Tibetan) besides
a vast reservoir of living traditions of ethanomedicine. Many
rural households in India, with limited access to organized
health services practise home remedies, the recipes and formulae
of which have been handed down from generation to genera-
tion. In Indian systems of medicine, generally the medicines of
plant origin are preferred over the medicines of animal origin
due to the presence of abundant natural ﬂora (Davis, 1994).
Liver is one of the chief storage organs for glucose reserve
in the body and plays a crucial role in the maintenance of
blood glucose homeostasis, because it consents to amass the
superﬂuous blood glucose and to demobilize it in hypoglyce-
mic states. Chronic hyperglycemia impedes normal inhibition
of hepatic glucose production persuaded by an acute escalation
of blood glucose level and enhances phosphoenolpyruvate car-
boxykinase gene expression, which is an imperative enzyme for
the regulation of gluconeogenesis (Shao et al., 2005). Further,
liver is the focal organ of oxidative and detoxifying processes
as well as free radical reactions and the biomarkers of oxida-
tive stress are elevated in the liver at an early stage in many dis-
eases, including diabetes mellitus (Stadler et al., 2003). In
experimental diabetes, streptozotocin exerts its toxic effects
on liver and other organs in addition to pancreatic cells. The
insulin insufﬁciency and hyperglycemia that result from cell
necrosis further augment liver damage through reactive freeradicals mediated lipid peroxidation of hepatocellular mem-
brane (Kume et al., 2004). This pathophysiological sequence
sets the scene for considering antioxidant therapy as an ad-
junct in the management of diabetes. Several studies have re-
cently dealt with either maintenance of antioxidant defense
of diabetic liver or reduction of peroxidative stress induced he-
patic damage in experimental models (Baydas et al., 2002; Cho
et al., 2002; Hu¨nkar et al., 2002). Hence, it is recommended
that a therapy with antioxidants may signify a useful pharma-
cologic overture to the management of diabetes.
The leaves of Crinum asiaticum are used as traditional heal-
ers in North east Solomon Islands to treat inﬂammation
(Wiart, 2000). Leaves are used for the treatment of skin disease
and inﬂammation. It has antibacterial activity (Ilavenil et al.,
2010). It is also used to treat ulcer and swelling (Goeltenboth
et al., 1991). The seeds are considered as purgative (Duke
and Ayensu, 1985). In Trobriands, the stem ﬁbers are used
for the treatment of Gonorrhoea. Hence, the present study is
aimed to investigate ameliorative potential of C. asiaticum
on hyperglycemia-mediated oxidative stress and hepatocyte
dysfunction in alloxan induced diabetic rats.2. Materials and methods
2.1. Plant material
C. asiaticum was collected in November month from Cauvery
river basin, Thanjavur, Tamil Nadu, India and then trans-
ferred to PRIST University, Thanjavur, Tamil Nadu, India.
It was taxonomically identiﬁed and authenticated by Rev.
Dr. S. John Britto SJ, Director, The Rapinat Herbarium and
Centre for Molecular Systematics, St. Joseph College (Auton-
omous), Tiruchirapalli, Tamil Nadu, India. The voucher spec-
imen was deposited at the Rapinat Herbarium and the voucher
number is RHCD BP15. The plant was extracted successfully
with ethanol by using soxhlet apparatus (Chopra et al., 1981).
2.2. Preparation of ethanolic extract of C. asiaticum leaves
Fresh leaves of C. asiaticum were air dried in shade and pow-
dered. The extraction was carried out by mixing the powdered
(800 g) leaves with 1:2 (w/v) in 70% ethanol (v/v) for 2 days.
The resulted extract was ﬁltered and concentrated by rotary
evaporator under reduced pressure and low temperature. The
yield of extract was 15% (w/w) in terms of dried starting
material.
2.3. Animals
Male albino Wistar rats of the same age group and body
weight of 140–160 g were selected for all the experiments.
The animals were housed in polypropylene cages at an ambient
temperature of 25–30 C and 45–55% of relative humidity with
Figure 1 Effect of ethanolic extract of Crinum asiaticum on
glucose level in control and experimental animals. Values are
expressed mean ± SEM of six animals. *P< 0.05, as compared to
diabetic induced.
Anti diabetic properties of Crinum asiaticum 17312 h each of dark and light cycles. Rats were fed with pellet
diet and water ad libitum. All the animal experimentations
were premeditated and executed in compliance with the ethical
norms approved by Ministry of Social Justices and Empower-
ment, Government of India and Institutional Animal Ethics
Committee Guidelines (743/03/abc/CPCSEA dt 3.3.03).
2.4. Induction of diabetes for experimental animals
Albino rats were made diabetic by a single intraperitoneal (IP)
injection of alloxan (200 mg/kg). Within 48 h after alloxan
administration, blood glucose concentrations were measured
via tail clip sampling. Animals with a blood glucose concentra-
tion 200 mg/dl were considered to be diabetic (Tanquilut et al.,
2009).
2.5. Experimental design
The animals were randomly divided into three groups: Group I:
control animals (normal, non-diabetic animals) (n= 6); Group
II: alloxan diabetic animals (n= 6); and Group III: alloxan
diabetic animals treated with ethanolic extract of C. asiaticum
leaves (n= 6). Ethanolic extract of C. asiaticum leaves was gi-
ven to experimental animals orally at a dosage of 200 mg/kg
daily for 15 days. After 15 days of treatment, the animals were
euthanized. Blood was collected and liver samples were dis-
sected out and washed immediately with ice cold saline to re-
move as much blood as possible, and immediately stored at
20 C until analysis. An extra sample of liver was excised
and ﬁxed in 10% formalin solution for histopathology analysis.
2.6. Biochemical assay
Aspartate transaminase, alanine transaminase, lactate dehy-
drogenase, alkaline phosphatase, acid phosphates, glucose,
cholesterol, triglyceride, low density lipoprotein, very low den-
sity lipoprotein and high density lipoprotein were estimated by
using commercially available kits according to the manufac-
turer’s instruction (AGGAPPE Diagnostic, Kerala and Ensure
Biotech Pvt., Hyderabad, India):
LDL ¼ ðtotal cholesterolÞ  ðHDL cholesterolÞ
 ðtriglyceride=5Þ
VLDL-cholesterol levels were calculated by using the follow-
ing formula (Prakasam et al., 2003):
VLDL ¼ triglyceride=5
The activities of enzymatic antioxidants such as SOD (Kak-
kar et al.,1984), catalase (Sinha, 1982) and non-enzymatic anti-
oxidants such as GSH (Ellman, 1959) were analysed. Levels of
lipid peroxides (Berton et al., 1998) were determined.Table 1 Effect of ethanolic extract of Crinum asiaticum on body w
Groups Body weight (g) L
Control 134.5 ± 1.3 4
Alloxan induced rats 107.0 ± 1.5 5
Alloxan + C. asiaticum 128.0 ± 1.2* 4
Values are expressed mean ± SEM of six animals.
*P< 0.05, as compared to diabetic induced rats.2.7. Histopathological studies
A portion of the liver was cut into two to three pieces of
approximately 6 mm3 size and ﬁxed in phosphate buffered
10% formaldehyde solution. After embedding in parafﬁn
wax, thin sections of 5 lm thickness of liver tissue were cut
and stained with haematoxylin–eosin. The thin sections of liver
were made into permanent slides and examined (Kleiner et al.,
2005) under high resolution microscope with photographic
facility and photomicrographs were taken.
2.8. Statistical analysis
Data were evaluated with SPSS/10 software hypothesis testing
methods that included one way analysis of variance (ANOVA)
followed by least signiﬁcant difference (LSD) test. P values of
less than 0.05 were considered to show statistical signiﬁcance.
All these results were expressed as mean ± SEM for six ani-
mals in each group.
3. Results
3.1. Body and organs weight
The body and organ weight of control and experimental rats
were given in Table 1. The total body weight decreased during
diabetes, but the individual organ weight like, liver, spleen and
kidney increased in diabetic rats when compared with control
rats. All the diabetic animals showed a progressive decrease in
body weight throughout study period. These changes were
alleviated to different extents by the rats administered with
ethanolic extract of C. asiaticum.eight in control and experimental animals.
iver (g) Kidney (g) Spleen (g)
.0 ± 0.01 0.87 ± 0.05 0.44 ± 0.01
.5 ± 0.04 1.02 ± 0.01 0.59 ± 0.01
.5 ± 0.30* 0.90 ± 0.04* 0.53 ± 0.03*
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The effect of ethanolic extract of C. asiaticum leaves on blood
glucose levels is shown in Fig. 1. The signiﬁcant increase in glu-
cose concentration in the diabetic animals than that of the con-
trol rats indicates a positive response for diabetes. The oral
administration of ethanolic extract of C. asiaticum signiﬁcantly
reduced the glucose level in serum when compared with allox-
an induced rats. Blood glucose levels of normal, diabetic rats
and treated animals were 117 ± 10.2, 230 ± 12.1 and
130 ± 9.3 mg/dl, respectively (P< 0.05).
3.3. Serum lipid proﬁle
Variation in the serum cholesterol levels of all groups were ob-
served at the end of the experimental periods (P< 0.05) as
presented in Table 2. Serum cholesterol levels were signiﬁ-
cantly increased in diabetic rats when compared with control
group of rats. However, rats administered with ethanolic ex-
tract of C. asiaticum leaves had signiﬁcantly reduced the serum
cholesterol levels in diabetic treated rats. In diabetic rats, a sig-
niﬁcant increase of serum LDL-cholesterol and VLDL-choles-
terol was observed as compared with control rats. But
decreases in HDL-cholesterol levels were observed. After, rats’
treatment with ethanolic extract of leaves of C. asiaticum was
found to reduce LDL-cholesterol (P< 0.05) and VLDL-cho-
lesterol and increase HDL-cholesterol in diabetic treated rats
(P< 0.05). Triglyceride levels in serum were increased signiﬁ-Table 2 Effect of ethanolic extract of C. asiaticum on lipid proﬁles
Groups Cholesterol (mg/dl) Triglyceride (mg
Control 83.00 ± 0.37 93.00 ± 0.37
Alloxan induced rats 244.44 ± 0.03 177.33 ± 0.49
Alloxan + C. asiaticum 107.00 ± 0.37* 102.00 ± 0.37*
Values are expressed mean ± SEM of six animals.
*P< 0.05, as compared to diabetic induced rats.
Table 3 Effect of ethanolic extract of C. asiaticum on serum mark
Groups AST (U/l) ALT (U/l)
Control 69.9 ± 0.04 11.7 ± 0.05
Alloxan induced rats 122.9 ± 0.24 29.1 ± 0.006
Alloxan + C. asiaticum 87.6 ± 0.14* 23.5 ± 0.15*
Values are expressed mean ± SEM of six animals.
*P< 0.05, as compared to diabetic induced rats.
Table 4 Effect of ethanolic extract of C. asiaticum on lipid peroxid
Groups MDA (nm/mg of protein) Catalase (U/mg
Control 1.62 ± 0.25 56.50 ± 0.22
Alloxan induced rats 5.36 ± 0.25 33.00 ± 0.36
Alloxan + C. asiaticum 2.15 ± 0.48* 48.17 ± 0.09*
Values are expressed mean ± SEM of six animals.
*P< 0.05, as compared to diabetic induced rats.cantly in diabetic rats as compared with normal rats. However,
these effects on rats administered with leaves of C. asiaticum
were reversed (P< 0.05).
3.4. Serum enzymes proﬁle (AST, ALT, LDH, ALP and ACP)
The study evaluated the activity of AST, ALT, LDH, ALP and
ACP in all the groups. A signiﬁcant elevation of AST, ALT,
LDH, ALP and ACP was observed in diabetic induced group
of rats. Moreover, treatment of diabetic rats with ethanolic ex-
tract of C. asiaticum resulted in signiﬁcant decreases in the lev-
els of serum AST, ALT, LDH, ALP and ACP when compared
with diabetic induced rats. A signiﬁcant level of reduction in
serum-marker enzymes (AST, ALT, LDH, ALP and ACP)
were noticed due to the effect of ethanolic extract of C. asiat-
icum leaves as indicated in Table 3.
3.5. Antioxidant and lipid peroxidation level
Table 4 illustrates the enzymic and non-enzymic antioxidant
status in control and experimental group of rats. There were
signiﬁcant decreases that were observed in alloxan induced
diabetic rates. However, administrations of ethanolic extract
of C. asiaticum leaves reversed the decrease level to near nor-
mal. There was a signiﬁcant elevation in serum LPO during
diabetes when compared to the control group. Administra-
tion of ethanolic extract tends to bring the values to near
normal.in control and experimental animals.
/dl) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl)
26.68 ± 0.06 37.82 ± 0.03 18.60 ± 0.03
14.31 ± 0.003 194.44 ± 0.04 35.46 ± 0.29
21.43 ± 0.003* 65.17 ± 0.05* 20.40 ± 0.16*
er enzymes in control and experimental animals.
LDH (U/l) ACP (KA units) ALP(KA units)
160.8 ± 0.29 6.55 ± 0.01 5.56 ± 0.02
320.7 ± 0.03 11.58 ± 0.02 13.50 ± 0.22
180.9 ± 0.01* 7.06 ± 0.03* 6.65 ± 0.02*
es and antioxidant status in control and experimental animals.
of protein) SOD (U/mg of protein) GSH (lg/mg of protein)
2.63 ± 0.01 31.58 ± 0.19
1.05 ± 0.07 14.80 ± 0.08
1.92 ± 0.02* 30.35 ± 0.09*
Figure 2 (A) Control histology liver showed intact hepatocytes (H), prominent nucleus (N), sinusoidal space (S) and central vein (CV).
(B) Alloxan induced rats showed damage deformation in central vein, enlargement of nucleus (EN), inﬁltration of cells (IF), degeneration
and loss of cell boundaries. Well developed hepatocyte with prominent nucleus and maintained sinusoidal space after Crinum asiaticum
(C) treatment.
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Fig. 2A–C illustrates histopathological investigation that also
provided an essential evidence for the biochemical analysis.
In control rats, liver sections showed normal hepatic cells with
well preserved cytoplasm, well-known nucleus, and nucleus
and central vein, where as alloxan induced group of rats
showed the number of morphological, fatty changes, balloon-
ing of hepatocytes and the loss of boundaries in the liver. How-
ever, treatment with C. asiaticum (200 mg/bw) improved the
histological architecture when compared to alloxan induced
diabetic rats.
4. Discussion
Management of diabetes with agents devoid of any side effects
is still a challenge to the medical system. This has led to an in-
crease in the demand for natural products with antihyperglyce-
mic activity and fewer side effects. Plants may act on blood
glucose through different mechanisms, some of them may have
insulin-like substances and some may inhibit insulinase activity
(Bopanna et al., 1997. Some plants are involved in the stimu-
lation of cells to produce more insulin (Chang and Johnson,
1980; Collier et al., 1987) and others may increase cells in
the pancreas by activating regeneration of pancreatic cells
(Chakravarthy et al., 1980).
Alloxan is the most commonly employed agent for the
induction of diabetes in experimental animal model. There is
increasing evidence that alloxan causes diabetes by rapid
depletion of b cells by DNA alkylation and accumulation of
cytotoxic free radicals that is suggested to result from initial is-
let inﬂammation, followed by inﬁltration of activated macro-
phages and lymphocyte in the inﬂammatory focus. It leads
to a reduction in plasma insulin concentration leading to a sta-ble hyperglycemia state (Szkudelski, 2001). In this study signif-
icant hyperglycemia was achieved after alloxan injection.
Alloxan induced diabetic rats with more than 200 mg/dl of
blood glucose level were considered to be diabetic and used
for the study.
The present study evaluated the changes in body weight and
organs weight in control, diabetic induced and treated animals
every week for the entire period of the study, as decrease in
body weight is considered as a marker for the development
of diabetes. Our results indicated a considerable change in
body and organs weight between alloxan induced and treated
rats. The treatment with ethanolic extract of C. asiaticum
showed a signiﬁcant increase in body weight in alloxan in-
duced diabetic rats.
The ethanol extract decreased the glucose level in alloxan
induced rats. Such an effect may be accounted for, in part,
by a decrease in the rats of intestinal glucose absorption,
achieved by an extra pancreatic action including the stimula-
tion of peripheral glucose utilization or enhancing glycolytic
and glycogenic process with concomitant decrease in glycogen-
olysis and glyconeogenesis (Luzi et al., 1997).
In uncontrolled diabetes mellitus was observed an increase
in total cholesterol, triglyceride, LDL, VLDL cholesterol with
decrease in HDL cholesterol, which contribute to coronary ar-
tery disease (Arvind et al., 2002). Lipids play an important role
in the pathogenesis of diabetes mellitus. Hyperlipidemia is a
recognized consequence of diabetes mellitus demonstrated by
the elevated levels of tissue cholesterol, phospholipids and free
fatty acids (Chakravarthy et al., 1980; Bopanna et al., 1997;
Ananthan et al., 2004). Diabetes-induced hyperlipidemia is
attributable to the excess mobilization of fat from the adipose
tissue due to the under utilization of glucose. The abnormal
high concentration of serum lipids in diabetes is mainly due
to the increase in the mobilization of free fatty acids from
176 S. Indradevi et al.the peripheral depots since insulin inhibits the hormone sensi-
tive lipase. On the other hand, glucagon, catecholamine, and
other hormones enhance lipolysis. The level of serum lipids
is usually raised in diabetes and such an elevation represents
a risk factor for coronary heart disease. However, the levels
of serum cholesterol and triglycerides were raised in diabetic
rats but were lowered signiﬁcantly with the treatment of C. asi-
aticum. It indicates that the ethanol extract of C. asiaticum is
more useful in the treatment of diabetes as it has hypolipidemic
effect. Moreover, its hypolipidemic effect could represent a
protective mechanism against the development of atheroscle-
rosis, which is usually associated with diabetes. Administration
of ethanolic extract of C. asiaticum reduced total cholesterol,
triglyceride, LDL, VLDL and improved HDL level.
Acid and alkaline phosphatase are a group of enzymes that
catalyse the hydrolysis of inorganic phosphate. These enzymes
are moderately increased in diabetic rats. Lactate dehydroge-
nase may be attributed to an increase in glucose utilization
through the pentose phosphate pathway (Grover et al.,
2000). Supplementation of C. asiaticum showed a signiﬁcant
decrease in enzyme level. The aspartate transaminase and ala-
nine transaminase (AST and ALT) are important liver marker
enzymes, which are increased during alloxan treatment. How-
ever, after treatment with ethanolic extract of C. asiaticum the
level of these enzymes were reduced when compared with dia-
betic induced group of rats. Similarly, many scientists have re-
ported that alloxan increased the activities of transaminases in
both liver and serum of diabetics. This increased level of trans-
aminases, which is active in the absence of insulin because of
the availability of amino acid in the blood of diabetics is
responsible for the increased gluconeogenisis and ketogenisis
metabolism in diabetics (Sumana and Suryawanshi, 2001).
Lipid peroxides are the secondary products of oxidative
stress and are unleashed as a result of the toxic effect of reac-
tive oxygen species produced during lipid peroxidation in dia-
betes (Evans et al., 2002). The elevated levels of lipid peroxides
in the liver tissues reveal the degree of lipid peroxidation in he-
patic tissues and are considered as the indicator of hepatocyte
damage (Albano, 2008). There are several reports in the liter-
ature that demonstrated the elevated levels of lipid peroxides
in the hepatic tissues of experimental diabetic models (Youssef
and McCullough, 2002). The results of the present study also
are in line with the previous studies, in which C. asiaticum
administration to diabetic group of rats notably declined the
levels of liver lipid peroxides. This normalization may be
accomplished by the antioxidant and free radical quenching
nature of C. asiaticum.
GSH is a major non-protein thiol in living organisms,
which plays a central role of co-ordinating the body’s antiox-
idants defence process. It is implicated in cellular defence
against xenobiotics and naturally occurring deleterious com-
pounds such as free radicals ( Bandyopadhyay et al., 1999).
The decrease in GSH level represents increased utilization
for neutralizing free radicals. However, administration of C.
asiaticum to alloxan induced rats attained near normal level.
It indicates that the plant extract possessed free radical scav-
enging nature.
Superoxide dismutase and catalase are considered as pri-
mary enzymes since they are involved in the direct elimination
of oxygen species (Aebi, 1983). Superoxide dismutase is an
important defence enzyme, which catalyses the dismutation
of superoxide radicals (Kakkar et al., 1984). And catalase isa hemoprotein, which catalyses the reduction of hydrogen per-
oxides and protects tissues from highly reactive hydroxyl rad-
icals. The reduced activity of superoxide dismutase and
catalase in the liver and kidney observed in diabetes may pose
deleterious effects as a result of the accumulation of superoxide
anion radicals and hydrogen peroxide.
A reduced activity of SOD and catalase in liver has been
observed during diabetes and this may result in a number of
deleterious effects due to the accumulation of superoxide rad-
icals and hydrogen peroxide. Plants extract treated rats
showed decreased lipid peroxidation, which is associated with
an increased activity of SOD and CAT. This means that the
extract can reduce reactive oxygen free radicals and improve
the activities of the hepatic antioxidant enzymes.
The hepatic tissue protective nature of C. asiaticum in con-
trol and experimental groups of rats were established by histo-
logical study. The diabetogenic potential of alloxan is
responsible for a progressive development of the hepatic tis-
sues lesions. The major pathological alteration observed in
the diabetic liver was the swelling of the capillaries, loss of cell
boundaries and central vein, the thickening of the capillary
walls. Most of the diabetic liver sections revealed the aug-
mented ﬁbrosis with plasmacytic inﬁltrate triggering distortion
of typical concentric arrangement of hepatocytes around the
central vein. The present studies address the histological ﬁnd-
ings in hepatocytes and their correlation with liver marker en-
zymes after C. asiaticum treatment in alloxan induced diabetic
rats. There was also congestion of portal vessels and sinusoids
and the veins were also dilated (Kleiner et al., 2005).
Therefore, the present investigation imparts novel informa-
tion on the hepatoprotective activity of C. asiaticum in alloxan
induced diabetic rats and provides more evidence that the pro-
tective effects are, possibly, due to a decline in oxidants by the
hepatic tissues. Further the oral administration of C. asiaticum
to alloxan induced diabetic rats exhibited signiﬁcant ameliora-
tive potential probably by attenuating the hyperglycemia-med-
iated oxidative stress. Further detailed studies are in progress
to elucidate the exact mechanism by which C. asiaticum elicits
its modulatory effects.References
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